Aeruginosin DA722
| Internal ID | 31c2c307-a337-4dd0-9f4b-5f0326d40bc6 |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides > Dipeptides |
| IUPAC Name | [(2S,3aS,6R,7aS)-2-[4-(diaminomethylideneamino)butylcarbamoyl]-1-[(2R)-2-[[(2R)-3-(3,5-dichloro-4-hydroxyphenyl)-2-hydroxypropanoyl]amino]-4-methylpentanoyl]-2,3,3a,4,5,6,7,7a-octahydroindol-6-yl] hydrogen sulfate |
| SMILES (Canonical) | CC(C)CC(C(=O)N1C2CC(CCC2CC1C(=O)NCCCCN=C(N)N)OS(=O)(=O)O)NC(=O)C(CC3=CC(=C(C(=C3)Cl)O)Cl)O |
| SMILES (Isomeric) | CC(C)C[C@H](C(=O)N1[C@H]2C[C@@H](CC[C@H]2C[C@H]1C(=O)NCCCCN=C(N)N)OS(=O)(=O)O)NC(=O)[C@@H](CC3=CC(=C(C(=C3)Cl)O)Cl)O |
| InChI | InChI=1S/C29H44Cl2N6O9S/c1-15(2)9-21(36-27(41)24(38)12-16-10-19(30)25(39)20(31)11-16)28(42)37-22-14-18(46-47(43,44)45)6-5-17(22)13-23(37)26(40)34-7-3-4-8-35-29(32)33/h10-11,15,17-18,21-24,38-39H,3-9,12-14H2,1-2H3,(H,34,40)(H,36,41)(H4,32,33,35)(H,43,44,45)/t17-,18+,21+,22-,23-,24+/m0/s1 |
| InChI Key | UVNFBGACXCESOX-PVPAWSFNSA-N |
| Popularity | 1 reference in papers |
| Molecular Formula | C29H44Cl2N6O9S |
| Molecular Weight | 723.70 g/mol |
| Exact Mass | 722.2267536 g/mol |
| Topological Polar Surface Area (TPSA) | 255.00 Ų |
| XlogP | 1.90 |
| Atomic LogP (AlogP) | 1.26 |
| H-Bond Acceptor | 9 |
| H-Bond Donor | 7 |
| Rotatable Bonds | 15 |
| CHEMBL3092720 |
| DTXSID501334780 |
| BDBM50494500 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.9100 | 91.00% |
| Caco-2 | - | 0.8616 | 86.16% |
| Blood Brain Barrier | - | 0.6000 | 60.00% |
| Human oral bioavailability | - | 0.7000 | 70.00% |
| Subcellular localzation | Mitochondria | 0.4252 | 42.52% |
| OATP2B1 inhibitior | - | 0.5729 | 57.29% |
| OATP1B1 inhibitior | + | 0.8252 | 82.52% |
| OATP1B3 inhibitior | + | 0.9367 | 93.67% |
| MATE1 inhibitior | - | 0.8000 | 80.00% |
| OCT2 inhibitior | - | 0.5000 | 50.00% |
| BSEP inhibitior | + | 0.9276 | 92.76% |
| P-glycoprotein inhibitior | + | 0.7237 | 72.37% |
| P-glycoprotein substrate | + | 0.8717 | 87.17% |
| CYP3A4 substrate | + | 0.7399 | 73.99% |
| CYP2C9 substrate | - | 0.6120 | 61.20% |
| CYP2D6 substrate | - | 0.7884 | 78.84% |
| CYP3A4 inhibition | + | 0.5074 | 50.74% |
| CYP2C9 inhibition | - | 0.6875 | 68.75% |
| CYP2C19 inhibition | - | 0.6295 | 62.95% |
| CYP2D6 inhibition | - | 0.8389 | 83.89% |
| CYP1A2 inhibition | - | 0.7297 | 72.97% |
| CYP2C8 inhibition | + | 0.6074 | 60.74% |
| CYP inhibitory promiscuity | - | 0.6692 | 66.92% |
| UGT catelyzed | + | 0.9000 | 90.00% |
| Carcinogenicity (binary) | - | 0.5135 | 51.35% |
| Carcinogenicity (trinary) | Non-required | 0.5721 | 57.21% |
| Eye corrosion | - | 0.9763 | 97.63% |
| Eye irritation | - | 0.9214 | 92.14% |
| Skin irritation | - | 0.7528 | 75.28% |
| Skin corrosion | - | 0.9086 | 90.86% |
| Ames mutagenesis | - | 0.5700 | 57.00% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.4533 | 45.33% |
| Micronuclear | + | 0.9100 | 91.00% |
| Hepatotoxicity | - | 0.5226 | 52.26% |
| skin sensitisation | - | 0.8253 | 82.53% |
| Respiratory toxicity | + | 0.8111 | 81.11% |
| Reproductive toxicity | + | 0.9000 | 90.00% |
| Mitochondrial toxicity | + | 0.6750 | 67.50% |
| Nephrotoxicity | - | 0.8426 | 84.26% |
| Acute Oral Toxicity (c) | III | 0.5776 | 57.76% |
| Estrogen receptor binding | + | 0.8048 | 80.48% |
| Androgen receptor binding | + | 0.7205 | 72.05% |
| Thyroid receptor binding | + | 0.5781 | 57.81% |
| Glucocorticoid receptor binding | + | 0.6658 | 66.58% |
| Aromatase binding | + | 0.6346 | 63.46% |
| PPAR gamma | + | 0.7313 | 73.13% |
| Honey bee toxicity | - | 0.7153 | 71.53% |
| Biodegradation | - | 0.7250 | 72.50% |
| Crustacea aquatic toxicity | - | 0.5300 | 53.00% |
| Fish aquatic toxicity | + | 0.9712 | 97.12% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.79% | 98.95% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.53% | 96.09% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 98.05% | 98.05% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 97.94% | 94.45% |
| CHEMBL3837 | P07711 | Cathepsin L | 97.65% | 96.61% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 97.63% | 91.11% |
| CHEMBL2179 | P04062 | Beta-glucocerebrosidase | 97.07% | 85.31% |
| CHEMBL4835 | P00338 | L-lactate dehydrogenase A chain | 97.02% | 95.34% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 96.91% | 98.33% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 96.20% | 83.82% |
| CHEMBL4361 | Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | 95.76% | 95.52% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 95.44% | 100.00% |
| CHEMBL1744525 | P43490 | Nicotinamide phosphoribosyltransferase | 94.85% | 96.25% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 94.70% | 97.21% |
| CHEMBL261 | P00915 | Carbonic anhydrase I | 94.28% | 96.76% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 94.10% | 91.19% |
| CHEMBL204 | P00734 | Thrombin | 94.07% | 96.01% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 93.65% | 93.56% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 93.51% | 96.00% |
| CHEMBL4072 | P07858 | Cathepsin B | 93.27% | 93.67% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 92.11% | 90.71% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 91.97% | 97.09% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 91.93% | 94.66% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 91.04% | 96.90% |
| CHEMBL238 | Q01959 | Dopamine transporter | 90.12% | 95.88% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 90.05% | 96.67% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 90.04% | 95.89% |
| CHEMBL4685 | P14902 | Indoleamine 2,3-dioxygenase | 89.77% | 96.38% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 89.44% | 95.89% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 89.29% | 100.00% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 89.23% | 97.14% |
| CHEMBL5701 | Q9H2K8 | Serine/threonine-protein kinase TAO3 | 89.19% | 96.67% |
| CHEMBL5646 | Q6L5J4 | FML2_HUMAN | 88.67% | 100.00% |
| CHEMBL5028 | O14672 | ADAM10 | 88.52% | 97.50% |
| CHEMBL3729 | P22748 | Carbonic anhydrase IV | 88.23% | 99.23% |
| CHEMBL4506 | Q96EB6 | NAD-dependent deacetylase sirtuin 1 | 87.16% | 88.33% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 86.21% | 100.00% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 85.88% | 97.50% |
| CHEMBL3384 | Q16512 | Protein kinase N1 | 85.10% | 80.71% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 84.89% | 96.11% |
| CHEMBL3880 | P07900 | Heat shock protein HSP 90-alpha | 84.72% | 96.21% |
| CHEMBL3492 | P49721 | Proteasome Macropain subunit | 84.45% | 90.24% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 84.21% | 96.47% |
| CHEMBL5261 | Q7L7X3 | Serine/threonine-protein kinase TAO1 | 84.05% | 89.33% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 83.98% | 95.56% |
| CHEMBL6136 | O60341 | Lysine-specific histone demethylase 1 | 83.87% | 95.58% |
| CHEMBL2553 | Q15418 | Ribosomal protein S6 kinase alpha 1 | 83.46% | 85.11% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 83.21% | 94.33% |
| CHEMBL222 | P23975 | Norepinephrine transporter | 83.09% | 96.06% |
| CHEMBL4805 | Q99572 | P2X purinoceptor 7 | 83.04% | 97.50% |
| CHEMBL245 | P20309 | Muscarinic acetylcholine receptor M3 | 81.21% | 97.53% |
| CHEMBL3976 | Q9UHL4 | Dipeptidyl peptidase II | 81.01% | 92.29% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 81.00% | 90.17% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 80.60% | 97.25% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 80.26% | 88.42% |
| CHEMBL5905 | Q04828 | Aldo-keto reductase family 1 member C1 | 80.11% | 91.79% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 80.08% | 82.69% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 80.05% | 99.17% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 73603914 |
| LOTUS | LTS0264912 |
| wikiData | Q77383101 |